Kaur R, Bhardwaj A, Gupta S. Cancer treatment therapies: traditional to modern approaches to combat cancers. Mol Biol Rep. 2023;50(11):9663–76.

Article  CAS  PubMed  Google Scholar 

Nasir A, et al. Nanotechnology, a tool for diagnostics and treatment of cancer. Curr Top Med Chem. 2021;21(15):1360–76.

Article  CAS  PubMed  Google Scholar 

Park MN, et al. Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy. Front Pharmacol. 2025;16:1504618.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Islam MR, et al. Colon cancer and colorectal cancer: prevention and treatment by potential natural products. Chem Biol Interact. 2022;368:110170.

Article  CAS  PubMed  Google Scholar 

Jang SY, et al. Immunomodulatory effects of a standardized botanical mixture comprising Angelica gigas roots and Pueraria lobata flowers through the TLR2/6 pathway in RAW 264.7 macrophages and cyclophosphamide-induced immunosuppression mice. Pharmaceuticals (Basel). 2025. https://doi.org/10.3390/ph18030336.

Article  PubMed  PubMed Central  Google Scholar 

Tewari D, et al. Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: a novel therapeutic strategy. Semin Cancer Biol. 2022;80:1–17.

Article  PubMed  Google Scholar 

Kumar S, Singh B, Singh R. Catharanthus roseus (L.) G. Don: a review of its ethnobotany, phytochemistry, ethnopharmacology and toxicities. J Ethnopharmacol. 2022;284:114647.

Article  CAS  PubMed  Google Scholar 

Banerjee S, et al. Anticancer properties and mechanisms of botanical derivatives. Phytomedicine Plus. 2023;3(1):100396.

Article  Google Scholar 

Li G, et al. Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms. Trends Cancer. 2022;8(1):65–80.

Article  PubMed  Google Scholar 

Chunarkar-Patil P, et al. Anticancer drug discovery based on natural products: from computational approaches to clinical studies. Biomed. 2024. https://doi.org/10.3390/biomedicines12010201.

Article  Google Scholar 

Atanasov AG, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20(3):200–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Simoben CV, et al. Challenges in natural product-based drug discovery assisted within silico-based methods. RSC Adv. 2023;13(45):31578–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iqbal J, et al. Plant-derived anticancer agents: a green anticancer approach. Asian Pac J Trop Biomed. 2017;7(12):1129–50.

Article  Google Scholar 

Ribeiro ARC, et al. Myrciaria tenella (DC.) O. Berg (Myrtaceae) leaves as a source of antioxidant compounds. Antioxidants. 2019. https://doi.org/10.3390/antiox8080310.

Article  PubMed  PubMed Central  Google Scholar 

Hashim GM, et al. Plant-Derived Anti-Cancer Therapeutics and Biopharmaceuticals. Bioengineering. 2025;12(1):7.

Article  CAS  Google Scholar 

Fujita K, et al. Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer. World J Gastroenterol. 2015;21(43):12234–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niu Z-X, et al. Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia. Eur J Med Chem. 2023;261:115827.

Article  CAS  PubMed  Google Scholar 

Montgomery B, Lin DW. Chapter 10 - TOXICITIES OF CHEMOTHERAPY FOR GENITOURINARY MALIGNANCIES. In: Taneja SS, editor. Complications of Urologic Surgery (Fourth Edition). Philadelphia: W.B. Saunders; 2010. p. 117–23.

Google Scholar 

Menis J, Twelves C. Eribulin (Halaven): a new, effective treatment for women with heavily pretreated metastatic breast cancer. Breast Cancer (Dove Med Press). 2011;3:101–11.

CAS  PubMed  PubMed Central  Google Scholar 

Gralla RJ, et al. Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and implications for patient management. Drugs. 2007;67(10):1403–10.

Article  CAS  PubMed  Google Scholar 

Nazha A, et al. Omacetaxine mepesuccinate (synribo) - newly launched in chronic myeloid leukemia. Expert Opin Pharmacother. 2013;14(14):1977–86.

Article  CAS  PubMed  Google Scholar 

Gallego-Jara J, et al. A compressive review about Taxol(®): history and future challenges. Mol. 2020. https://doi.org/10.3390/molecules25245986.

Article  Google Scholar 

Chihomvu P, et al. Phytochemicals in drug discovery—a confluence of tradition and innovation. Int J Mol Sci. 2024;25(16):8792.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naeem A, et al. Natural products as anticancer agents: current status and future perspectives. Mol. 2022. https://doi.org/10.3390/molecules27238367.

Article  Google Scholar 

Jacob S, et al. Solid lipid nanoparticles and nanostructured lipid carriers for anticancer phytochemical delivery: advances, challenges, and future prospects. Pharmaceutics. 2025;17(8):1079.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gupta PK, et al. Phytomedicines targeting cancer stem cells: therapeutic opportunities and prospects for pharmaceutical development. Pharmaceuticals. 2021;14(7):676.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sahrawat TR. Role of artificial intelligence and machine learning in sustainable drug discovery. Braz Arch Biol Technol. 2024;67:e24240538.

Article  Google Scholar 

Kim H, et al. Artificial intelligence in drug discovery: a comprehensive review of data-driven and machine learning approaches. Biotechnol Bioprocess Eng. 2020;25(6):895–930.

Article  CAS  PubMed  Google Scholar 

Liu H, Tang T. MAPK signaling pathway-based glioma subtypes, machine-learning risk model, and key hub proteins identification. Sci Rep. 2023;13(1):19055.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y, et al. Designing combination therapies with modeling chaperoned machine learning. PLoS Comput Biol. 2019;15(9):e1007158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiménez-Luna J, et al. Artificial intelligence in drug discovery: recent advances and future perspectives. Expert Opin Drug Discov. 2021;16(9):949–59.

Article  PubMed  Google Scholar 

Lavecchia A. Machine-learning approaches in drug discovery: methods and applications. Drug Discov Today. 2015;20(3):318–31.

Article  PubMed  Google Scholar 

Serghini A, Portelli S, Ascher DB. AI-driven enhancements in drug screening and optimization. Methods Mol Biol. 2024;2714:269–94.

Article  CAS  PubMed  Google Scholar 

Wu Y, et al. The role of artificial intelligence in drug screening, drug design, and clinical trials. Front Pharmacol. 2024. https://doi.org/10.3389/fphar.2024.1459954.